Use of long‐acting cabotegravir and rilpivirine in people living with HIV : A prospective observational cohort study

Key Points

• This research aims to evaluate the effectiveness and safety of long-acting cabotegravir and rilpivirine in HIV treatment.
• Prospective observational cohort design
• Participants living with HIV
• Monitoring of treatment outcomes and safety
• Comparison to standard treatment approaches
• CAB+RPV LA shows effectiveness as a treatment option
• Safety profiles similar to other therapies
• Durability of treatment outcomes observed over the study period